AlphaYou
Overview
Smart money at a glance
Filings to Oct 2, 2026Net selling: insiders sold $6.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$6.3M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 2- Open
- $28.46
- 52-wk high
- $30.00
- High
- $29.58
- 52-wk low
- $17.34
- Low
- $28.17
- Prev close
- $28.46
- Mkt cap
- $1.69B
- Volume
- 616.8K
- P/S
- 15.8x
- P/B
- 6.8x
- Profit margin
- -140.4%
- Op margin
- -121.6%
- ROE
- -73.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about KMTS filings
Are insiders buying or selling Kestra Medical Technologies, Ltd. Common Stock (KMTS) stock?
Net selling: insiders sold $6.3M and bought $0 of KMTS stock on the open market in the 90 days to Oct 2, 2026, according to SEC Form 4 filings. $1.6M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Webster, Brian Daniel (See Remarks), who sold $2.7M. The latest filing was on Oct 1, 2026.
Which members of Congress have traded KMTS recently?
None. No member of Congress disclosed a KMTS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this KMTS smart-money data?
This summary uses filings available on Oct 2, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- SS
State Street
$1.8M
added
What insiders are doing
How top traders are positioned
No tracked top-trader positions in KMTS right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 23.0% below what analysts expected.
Earnings per share
-$0.61 expected
What the street expects next
Financials
What it sold, what it cost, what was left.
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $22.6M | $24.6M | $28.6M | $31.0M |
| Cost of what it sold | $11.1M | $11.6M | $13.0M | $13.5M |
| Gross profit | $11.4M | $12.9M | $15.7M | $17.5M |
| What it spent | ||||
| Research and development | $4.9M | $5.0M | $5.6M | $6.8M |
| Sales and admin | $38.3M | $42.7M | $49.4M | $48.4M |
| Total operating expenses | $43.2M | $47.7M | $55.0M | $55.2M |
| What was left | ||||
| Operating profit | -$31.8M | -$34.8M | -$39.3M | -$37.7M |
| Interest on debt | $1.9M | $1.9M | $1.8M | $1.9M |
| Profit before tax | -$32.8M | -$34.1M | -$38.6M | -$44.0M |
| Tax | $34.0K | $35.0K | $192.0K | $50.0K |
| Net profit | -$32.8M | -$34.2M | -$38.8M | -$44.1M |
| EBITDA | -$28.5M | -$30.3M | -$50.1M | -$35.0M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace